Cytomos

Cytomos, an Edinburgh-based biotechnology company, has raised £5 million to scale up production of its unique cell analysis technology. The oversubscribed funding round was led by existing investors Archangels with participation from Old College Capital, Scottish Enterprise and British Busines

The corporate group at Burges Salmon has advised Cytomos, an Edinburgh-based life science company, on a £4m funding package to support the development of cell analysis solutions for the biopharma industry and fast-track novel therapies to market. The investment round was led by existing invest

Edinburgh-based life science firm Cytomos has successfully raised £4 million in a recent investment round for the development and market-testing of its Cytomos Dielectric Spectroscopy (CDS) technology. Archangels led this funding initiative with participation from notable investors such as Old

Cytomos, an Edinburgh-based life science company that has developed a proprietary new approach to analysing cells, has secured £1.6 million funding to progress the development and qualification of its novel cell analysis platform, Cytomos Dielectric Spectroscopy (CDS). The fundraising round by